|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01696 SISRAM MED
Nominal 
3.540 +0.080 (+2.312%) | 2024/06 - Interim USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 43,936 | 22,039 | 32,377 | 25,737 |
| Net Cash from / (used in) Investing Activities | -- | (32,995) | (52,113) | (46,767) | (33,509) |
| Net Cash from / (used in) Financing Activities | -- | (20,966) | (17,847) | 55,777 | (12,212) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (10,025) | (47,921) | 41,387 | (19,984) |
| Cash & Cash Equivalents at beginning of period | -- | 74,793 | 124,920 | 83,373 | 99,735 |
| Effect of Foreign Exchange Rate Changes | -- | (4,233) | (2,206) | 160 | 3,622 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 60,535 | 74,793 | 124,920 | 83,373 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | USD 10,952,000 |
| %Change | -42.050% |
| EPS / (LPS) | USD 0.023 |
| NBV Per Share ($) | USD 0.967 |